HIRSCHMAN ORIN 13D/13G Filings for Aprea Therapeutics, Inc. (APRE)

HIRSCHMAN ORIN 13D and 13G filings for Aprea Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-10
08:36 am
Purchase		 2024-12-31 13G Aprea Therapeutics, Inc.
APRE		 HIRSCHMAN ORIN 539,300
9.900%		 190,000increase
(+54.39%)		 Filing
2024-02-07
6:55 pm
Purchase		 2023-12-31 13G Aprea Therapeutics, Inc.
APRE		 HIRSCHMAN ORIN 349,300
11.000%		 4,300increase
(+1.25%)		 Filing
2023-03-03
06:03 am
Purchase		 2023-02-23 13G Aprea Therapeutics, Inc.
APRE		 HIRSCHMAN ORIN 345,000
11.000%		 345,000increase
(New Position)		 Filing